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Background and purpose — The Lubinus SP II stem is well docu-
mented in both orthopedic registries and clinical studies. World-
wide, the most commonly used stem lengths are 150 mm and 170 
mm. In 1995, the 130-mm stem was introduced, but no outcome 
data have been published. We assessed the long-term survival of 
the Lubinus SP II 130-mm stem in primary total hip arthroplasty.
Patients and methods — In a retrospective cohort study, we 
evaluated 829 patients with a Lubinus SP II primary total hip 
arthroplasty (932 hips). The hips were implanted between 1996 
and 2001. The primary endpoint was revision for any reason. The 
mean follow-up period was 10 (5–15) years.
Results — Survival analysis showed an all-cause 10-year sur-
vival rate of the stem of 98.7% (95% CI: 99.7–97.7), and all-cause 
10-year survival of the total hip arthroplasty was 98.3% (95% CI: 
99.3–97.3).
Interpretation — Excellent long-term results can be achieved 
with the cemented Lubinus SP II with the relatively short 130-mm 
stem. This stem has potential advantages over its 150-mm and 
170-mm siblings such as bone preservation distal to the stem, 




The  Lubinus  SP  II  stem  is  a  well-documented  prosthesis 
(Annaratone  et  al.  2000,  Lubinus  et  al.  2002,  Catani  et  al. 
2005, Wierer  et  al.  2013).  The  anatomical-shaped  SP  stem 
was introduced in 1982 as a monoblock prosthesis, and since 
1984 it has been available as the modular SP II system. The 
anatomical-shaped  stem  provides  a  uniform  cement  mantle 
surrounding the prosthesis, which reduces the risk of contact 
between the prosthesis and cortical bone. It has been hypoth-
esized  that  this  more  uniform  cement  mantle  improves  the 
survival of  the prosthesis  (Lubinus et  al. 2002). Worldwide, 
the most commonly used stem lengths are 150 and 170 mm. 
In 1995, the 130-mm stem was introduced and since its intro-







stem.  Reports  on  150-mm  and  170-mm  SP  II  stems  show 














Data  were  extracted  from  the  medical  registration  system, 
calling the patients and consulting the patients’ (former) gen-
eral practitioners (GPs). If patients had died, their relatives or 
GPs were asked  if  any  revision of  the  total hip arthroplasty 
had occurred.















stock  due  to  secondary  osteoarthritis  (e.g.  posttraumatic). 




lox-forte  ceramic  head  (CeramTec,  Plochingen,  Germany). 
All components were cemented using Simplex bone cement 
(Stryker).
The  Lubinus  SP  II  is  an  anatomical,  S-shaped  modular 
stem (of Co-Cr-Mo) with an anatomical anteversion and a 12- 






829  patients  (932  hips)  were  included  in  the  study.  103 
patients were operated bilaterally (Table 1). The mean follow-
up period was 10 (5–15) years. During the follow-up period, 











Perioperatively,  systemic  antibiotic  prophylaxis  was  given 
(cefazoline).  Patients  received  low-molecular-weight  hepa-
rin (LMWH) until adequate INR, and a vitamin K antagonist, 






follow-up measurement  until April  30,  2012. Kaplan-Meier 
survival analyses were performed for the total hip arthroplasty, 
the cup, and the stem. We also performed analysis of the first 









 Mean, years (SD) 72 (8.0)
Sex 
 Men  223 (24%)
 Women  709 (76%)
Side of surgery 
 Right  467 (50%)
 Left  465 (50%)
Preoperative diagnosis 
 Primary osteoarthritis  863 (93%)
 Secondary osteoarthritis    52 (5.6%)
 Inflammatory diseases    35 (3.8%)
 Avascular necrosis      6 (0.6%)
 Childhood diseases      1 (0.1%)
 Other    10 (1.1%)
 Fracture    17 (1.8%)
Stem size 
 01    15 (1.6%)
 1  268 (29%)
 2  277 (30%)
 3  247 (27%)
 4  123 (13%)
 5      1 (0.1%)
Figure 1. The anatomical S-shaped Lubinus SP II stem.



































and  for  all-cause  revision. The  relatively  unknown 130-mm 
SP  II  stem  has  several  potential  advantages  over  the  larger 
150-mm and 170-mm stems. First, the shorter stem preserves 
bone  distal  to  the  prosthesis.  Secondly,  the  proximal  filling 














The  study  had  some  potential  weaknesses.  First,  we  did 







There  is  an  ongoing  discussion  about  whether  to  use 
cemented or uncemented designs (Hailer et al. 2010, Corten 
Figure 2. Survival curves for the THA and stem: all-
cause survival of the THA (blue line), all-cause sur-
vival of the stem (green line), and aseptic survival of 
the stem (orange line). Dotted lines show confidence 
intervals for the respective survival curves. 
Table 2. Survival rates at 10 years for THA, stem, and cup a (with all hips included)
 THA (95% CI) Stem (95% CI) Cup (95% CI)
Revision for any reason 98.3 (99.3–97.3) 98.7 (99.7–97.7) 98.7 (99.7–97.7)
Aseptic loosening 99.2 (99.9–98.4) 99.4 (99.9–98.4) 99.7 (100–99.3)
a
 After 10 years, 406 patients were at risk. 
Table 3. Survival rates at 10 years for THA, stem, and cup a a (with only the first 
implanted hip included)
 THA (95% CI) Stem (95% CI) Cup (95% CI)
Revision for any reason 98.6 (99.6–97.6) 98.9 (99.9–97.9) 99.0 (99.8–98.2)
Aseptic loosening 99.4 (100–98.6) 99.3 (99.9–98.7) 99.8 (100–99.4)
a
 After 10 years, 357 patients were at risk.
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et al. 2011). A recently published randomized controlled trial 










Compared  to  commonly  used  straight  stem  designs,  the 
anatomical-shaped Lubinus SP II has better centralization of 













is most  likely  due  to  better  proximal filling  and  line-to-line 












cause and 99% for aseptic  loosening) of  the  relatively short 
cemented Lubinus SP II 130-mm stem. Because of the excel-
lent survival rate, preservation of bone stock, and the advan-
tages  in  revision  hip  arthroplasty, we  recommend  using  the 
130-mm SP II stem over use of its longer siblings.
WP: data collection and writing of the article. RM: data collection and super-
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